The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: Possible modulatory effects by transforming growth factor beta 1

Diabetologia

Volumn 42, Issue 6, 1999, Pages 748-757

  Jude, E B ^a   Boulton, A J M ^a   Ferguson, M W J ^b   Appleton, I ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Arginase; Diabetic neuropathy; Foot ulcers; Nitric oxide; NOS

Indexed keywords

ARGINASE; ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AMINO ACID METABOLISM; ARTICLE; CALLUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; FEMALE; FIBROBLAST; HUMAN; MACROPHAGE; MALE; PATHOGENESIS; PRIORITY JOURNAL; WOUND HEALING;

ARGINASE; BLOTTING, WESTERN; DIABETIC FOOT; FEMALE; HUMANS; ISOENZYMES; MACROPHAGES; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRITES; SKIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033040323     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051224     Document Type: Article

References (35)

1. 1. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA (1989) Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 12: 24-31
2. 2. Williams DRR (1985) Hospital admissions of diabetic patients: information from hospital activity analysis. Diabet Med 2: 27-32
3. 3. Boulton AJM (1997) Foot problems in patients with diabetes mellitus. In: Pickup JC, Williams G (eds) Textbook of diabetes. Blackwell Science 2nd edn., pp 58; 1-58
4. 3. Boulton AJM (1997) Foot problems in patients with diabetes mellitus. In: Pickup JC, Williams G (eds) Textbook ofdiabetes. Blackwell Science 2nd edn., pp 58; 1-58
5. 4. Thomson FJ, Veves A, Ashe H et al. (1991) A team approach to diabetic foot care - the Manchester experience. The Foot 2: 75-82
6. 5. Appleton I, Tomlinson A, Willoughby DA (1996) Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv Pharmacol 35: 27-78
7. 6. Kolls J, Xie J, LeBlanc R et al. (1994) Rapid induction of messenger RNA for nitric oxide synthase II in rat neutrophils in vivo by endotoxin and its suppression by prednisolone. Proc Soc Exp Biol Med 205: 220-225
8. 7. Granger DL, Hibbs JB Jr, Perfect JR, Durack DT (1988) Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest 81: 1129-1133
9. 8. Drapier J-C, Hibbs JB Jr (1988) Differentiation of murine macrophages to express non-specific cytotoxicity for tumour cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 140: 2829-2838
10. 9. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157: 87-94
11. 10. Stuehr DJ, Nathan CF (1989) Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J Exp Med 169: 1543-1555
12. 11. Hibbs JB Jr, Vavrin Z, Taintor RR (1987) L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138: 550-565
13. 12. Culcasi M, Lafon-Cazal M, Pietri S, Bockaert J (1994) Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J Biol Chem 269: 12589-12593
14. 13. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM (1992) Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267: 24173-24176
15. 14. Gartner ME, Shearer JD, Bereiter DF, Mills CD, Caldwell MD (1991) Wound fluid amino acid concentrations regulate the effect of epidermal growth factor on fibroblast replication. Surgery 110: 448-456
16. 15. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266: 4244-4250
17. 16. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624
18. 17. Selmeci L, Brosnan ME, Seiler N (1985) Recent progress in polyamine research. Akademiai Kiado, Budapest
19. 18. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72: 248-254
20. 19. Corraliza IM, Campo ML, Soler G, Modolell M (1994) Determination of arginiase activity in macrophages: a micromethod. J Immunol Methods 174: 231-235
21. 20. Mulligan MS, Warren JS, Smith CW et al. (1992) Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginine. J Immunol 148: 3086-3092
22. 21. Ferguson MWJ, Herrick SE, Spencer MJ, Shaw JE, Boulton AJM, Sloan P (1996) The histology of diabetic foot ulcers. Diabet Med 13: S30-S33
23. 22. Tentolouris N, Jude EB, Ferguson MWJ, Appleton I, Boulton AJM (1998) Increased plasma nitric oxide in the aetiopathogenesis of recurrent neuropathic foot ulceration in diabetic patients. Diabet Med [Suppl 2]: 105
24. 23. Stevens BR, Sutherland DER, Ansite JD et al. (1997) Insulin down regulates the inducible nitric oxide synthase pathway: nitric oxide as cause and effect of diabetes? J Immunol 159: 5329-5335
25. 24. Veves A, Akbari CM, Primavera J et al. (1998) Endothelial synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47: 457-463
26. 25. Albina JE, Mills CD, Henry WL, Caldwell MD (1990) Temporal expression of different pathways of L-arginine metabolism in healing wounds. J Immunol 144: 3877-3880
27. 26. Vane JR, Mitchell JA, Appleton I et al. (1994) Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA 91: 2046-2050
28. 27. Boutard V, Havouis R, Fouqueray B, Philippe C, Moulinoux JP, Baud L (1995) Transforming growth factor beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J Immunol 155: 2077-2084
29. 28. Schmidt P, Cox D, McMasteer G et al. (1993) TGF-βs and TGF-β Type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol 171: 191-197
30. 29. Griscavage JM, Rogers NE, Sherman MP, Ignarro LG (1993) Inducible nitric oxide synthase from a rat alveolar cell line is inhibited by nitric oxide. J Immunol 151: 6329-6337
31. 30. Szabo C, Southan GJ, Wood E, Thiemermann C, Vane JR (1994) Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: requirement of a serum factor. Br J Pharmacol 112: 355-356
32. 31. Hrabak A, Bajor T, Temesi A, Meszaros G (1996) The inhibitory effect of nitrite a stable product of nitric oxide (NO) formation, on arginase. FEBS Lett 390: 203-206
33. 32. Ausprunk DH, Knighton DR, Folkman J (1994) Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev Biol 38: 237-248
34. 33. Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Persteris P, Maragoudakis ME (1994) Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902
35. 34. Thornton FJ, Ahrendt GM, Schaffer MR, Tantry US, Barbul A (1997) Sepsis impairs anastomotic collagen gene expression and synthesis: a possible role for nitric oxide. J Surg Res 69: 81-86